Related Experiment Video
Updated: Jan 16, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Cerebral Sinovenous Thrombosis: 20 Years of Experience in a Pediatric Tertiary Center
Julia Loureiro Sion1, Daniele M Celeste2, Bernadete L Liphaus3,4
1Pediatric Hematology Unit, Instituto Da Criança e do Adolescente, Hospital Das Clínicas, Faculdade De Medicina, Universidade De São Paulo, Sao Paulo, Brazil.
Insights
Cerebral sinovenous thrombosis (CSVT) in children is often linked to infections and dehydration. Anticoagulation treatment, though lengthy, showed good outcomes with no fatalities or recurrences in this pediatric study.
Area of Science:
- Pediatric Neurology
- Hematology
Background:
- Cerebral sinovenous thrombosis (CSVT) is an uncommon but serious condition in children.
- Identifying risk factors and optimizing treatment are crucial for pediatric CSVT management.
Purpose of the Study:
- To analyze risk factors, treatment strategies, and outcomes of pediatric CSVT.
- To evaluate the effectiveness and safety of anticoagulation in pediatric CSVT cases.
Main Methods:
- Retrospective analysis of 44 pediatric CSVT cases from a 20-year registry.
- Identification of risk factors, including infections and thrombophilia.
- Review of anticoagulation treatments (low molecular weight heparin, unfractionated heparin) and their duration.
Main Results:
- Risk factors were identified in 93% of cases, with infection being most common.
- Anticoagulation was administered to 91% of patients, with treatment durations exceeding current guidelines.
- Complete resolution of thrombi occurred in 49% of cases, with no recurrences or fatalities related to anticoagulation.
Conclusions:
- Infections are a primary risk factor for pediatric CSVT.
- Extended anticoagulation may be effective and safe in pediatric CSVT, despite exceeding current recommendations.
- Pediatric CSVT patients treated with anticoagulation demonstrate favorable outcomes with high rates of thrombus resolution.
Abstract:
Cerebral sinovenous thrombosis (CSVT) is rare in children and is related to risk factors, as dehydration and infections. This study analyzed 44 pediatric cases of CSVT from a 20-year registry. Risk factors were identified in 93%, infection being the most frequent. Thrombophilia was detected in eight patients. Most patients (91%) received anticoagulation: 78% low molecular weight heparin and 20% unfractionated heparin. Treatment duration exceeded current recommendations (median 21 weeks), as most cases were treated based on CHEST 2012 guidelines. One patient experienced major bleeding related to anticoagulation. All thrombi improved, with 49% achieving complete resolution. There were no recurrences and no fatalities linked to anticoagulation.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

